Literature DB >> 26370323

U-shaped relationship between uric acid and residual renal function decline in continuous ambulatory peritoneal dialysis patients.

Yao-Peng Hsieh1,2,3,4, Yu Yang1,4, Chia-Chu Chang1,4, Chew-Teng Kor1, Yao-Ko Wen1, Ping-Fang Chiu1,4, Chi-Chen Lin5.   

Abstract

AIM: There is little information on the relationship between uric acid (UA) and residual renal function (RRF) in continuous ambulatory peritoneal dialysis (CAPD). The aim of this research is to study the influence of UA on RRF decline in CAPD patients.
METHODS: A retrospective observational cohort study of 304 patients who started CAPD without anuria between 2001 and 2010 was conducted at a single medical center. The outcomes measured in the study included the rate of RRF decline and anuria. A multiple ordinal logistic regression model with backward elimination was conducted to determine the independent factors of the slope of RRF decline. A Cox proportional hazard model was conducted to determine the independent variables of time to anuria.
RESULTS: The average rate of RRF decline was -0.12 ± 0.22 mL/min per month. Multivariate analysis showed that lower UA group (<0.372 mmol/L), higher UA group (≧0.421 mmol/L), male gender, diabetes mellitus (DM), the use of calcium channel blocker (CCB), and RRF at baseline were linked positively with the rate of RRF decline; on the other hand, independence in dialysate exchanges and BUN were negatively associated with the risk of RRF decline. In addition, male gender, DM, diuretics, and CCB were associated with a higher risk of progression to anuria, whereas 24-h urine amount at baseline conferred a protective role in the development of anuria.
CONCLUSIONS: A U-shaped relationship was found between UA levels and the rate of RRF decline in patients on CAPD, with a faster decline rate in those of higher and lower UA groups.
© 2015 Asian Pacific Society of Nephrology.

Entities:  

Keywords:  continuous ambulatory peritoneal dialysis; end stage renal disease; residual renal function; time to anuria; uric acid

Mesh:

Substances:

Year:  2017        PMID: 26370323     DOI: 10.1111/nep.12613

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  5 in total

Review 1.  Advances in Understanding and Management of Residual Renal Function in Patients with Chronic Kidney Disease.

Authors:  Xin Liu; Chunsun Dai
Journal:  Kidney Dis (Basel)       Date:  2016-09-07

2.  Serum uric acid concentration and blood pressure level in hemodialysis patients.

Authors:  Viroj Wiwanitkit
Journal:  J Nephropharmacol       Date:  2015-10-19

3.  A longitudinal analysis of the relationship between serum uric acid and residual renal function loss in peritoneal dialysis patients.

Authors:  Chiehlun Yang; Xinxin Ma; Wenbo Zhao; Yanru Chen; Hongchun Lin; Dan Luo; Jun Zhang; Tanqi Lou; Yu Peng; Hui Peng
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

4.  Serum uric acid level and all-cause and cardiovascular mortality in peritoneal dialysis patients: A systematic review and dose-response meta-analysis of cohort studies.

Authors:  Ting Kang; Youchun Hu; Xuemin Huang; Adwoa N Amoah; Quanjun Lyu
Journal:  PLoS One       Date:  2022-02-22       Impact factor: 3.240

5.  High serum uric acid level is a mortality risk factor in peritoneal dialysis patients: a retrospective cohort study.

Authors:  Shilong Xiang; Xiaohui Zhang; Xishao Xie; Junni Wang; Qin Zhou; Zhimin Chen; Yaomin Wang; Guangjun Liu; Fei Han; Jianghua Chen
Journal:  Nutr Metab (Lond)       Date:  2019-08-01       Impact factor: 4.169

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.